Загрузка страницы

Exabeam Case Study: Allergan (Part 1)

Michael Towers, CISO of Allergan talks about the threats they face and how Exabeam allows them to proactively detect indicators of Insider threat incidents before they happen.
Subscribe to Exabeam for more: http://bit.ly/2SFgiiM

Allergan plc (NYSE: AGN), headquartered in Dublin, Ireland, is a global pharmaceutical leader focused on developing, manufacturing and commercializing branded pharmaceutical, device, biologic, surgical and regenerative medicine products for patients around the world.

GET A DEMO:
Get a hands-on demo of the Exabeam products: https://www.exabeam.com/demo

ABOUT EXABEAM:
Exabeam is a global cybersecurity leader that delivers AI-driven security operations. The company was the first to put AI and machine learning in its products to deliver behavioral analytics on top of security information and event management (SIEM). Today, the Exabeam Security Operations Platform includes cloud-scale security log management and SIEM, powerful behavioral analytics, and automated threat detection, investigation and response (TDIR). Its cloud-native product portfolio helps organizations detect threats, defend against cyberattacks, and defeat adversaries. Exabeam learns normal behavior and automatically detects risky or suspicious activity so security teams can take action for faster, more complete response and repeatable security outcomes.

Detect. Defend. Defeat.™ Learn how at: https://www.exabeam.com/

CONNECT WITH US:
Twitter: https://twitter.com/exabeam
Instagram: https://www.instagram.com/exabeam/
LinkedIn: https://www.linkedin.com/company/exabeam/
Blog: https://www.exabeam.com/blog/

Видео Exabeam Case Study: Allergan (Part 1) канала Exabeam
Показать
Комментарии отсутствуют
Введите заголовок:

Введите адрес ссылки:

Введите адрес видео с YouTube:

Зарегистрируйтесь или войдите с
Информация о видео
1 апреля 2018 г. 3:22:48
00:03:42
Яндекс.Метрика